Our pre-clinical work has the potential to drastically improve treatment for people living with Parkinson’s disease.

Our aim is to validate a unique neural signal (ERNA) discovered in the brain of people with Parkinson’s disease as a feedback signal that correlates with the state of Parkinson’s disease symptoms. The correlation between changes in the neural signal and changes in motor symptom state will be studied, and the successful development of an adaptive deep brain stimulation system will mean that it will cause far less side-effects from inadequate stimulation control, greatly improving the quality of life of patients suffering from Parkinson’s disease.

If you would like to help support our research and make a donation please click here.

Further information

Click here to download our factsheet.

Research team

Program leader: A/Prof James Fallon

Team members: Dr Wesley Thevathasan, Dr Joel Villalobos, Prof Hugh McDermott, Dr Tomoko Hyakumara, Dr Wendy Adams, Mr Nicholas Sinclair 

PhD researcher: Mr Michael Warburton

Collaborators: Mr Kristian Bullus, Dr Peter McNeill